Pot Stocks To Watch In 2025

These Marijuana Stocks Could See A Rise In Trading In 2026

The push for better cannabis reform is and seems to be an ongoing battle. Now, from the time the first state legalized cannabis, there has been tremendous growth and opportunity. This led other states and global regions to take action and build an entire cannabis industry. This has allowed investors to enter the space and find cannabis companies that are publicly traded. Investing in top marijuana stocks is the quickest way to get involved from the sidelines.

Yet some are more invested directly in the business, for example, farmers and dispensary owners. Legal operators face another challenging year, which once again will impact the trading for most marijuana stocks today. Now, for any reason, this upcoming year leads to the passing of federal reform that would have the best outcome for marijuana stock investors. For the moment, it’s watch and see what takes place in the sector.

Meaning, the outcome of this new bill and other laws will determine the trading behavior for most pot stocks in the sector. Still, now is as good a time as any to get prepared and educated on legal cannabis and how to invest. 2026 is showing to be a strong year if lawmakers can finally get reform passed that helps the industry as a whole. Below are several marijuana stocks to watch this upcoming year.

Top Marijuana Stocks For Investors

Innovative Industrial Properties, Inc. (NYSE:IIPR)
Chicago Atlantic Real Estate Finance, Inc.(NASDAQ:REFI)
NewLake Capital Partners, Inc. (OTC:NLCP)

Innovative Industrial Properties, Inc.

Innovative Industrial Properties, Inc. is a real estate investment trust (REIT) focused on the acquisition, ownership, and management of specialized industrial properties and life science real estate. iipr

In more recent news, the company released its Q3 2025 earnings back in early November.

Highlights And Key Mentions

  • Total revenues of $64.7 million and net income attributable to common stockholders of $28.3 million, or $0.97 per share.
  • Adjusted funds from operations (“AFFO”) and normalized funds from operations of $48.3 million and $45.2 million, respectively.
  • Paid a quarterly dividend of $1.90 per common share on October 15, 2025, to stockholders of record as of September 30, 2025.
    13% debt to total gross assets, with $2.7 billion in total gross assets.

[Read More] 3 Marijuana Stocks To Watch That Could Make A Profit In 2026

Chicago Atlantic Real Estate Finance, Inc.

Chicago Atlantic Real Estate Finance, Inc. operates as a commercial mortgage real estate investment trust in the United States. 

Back in early November 2025, the company reported its Q3 2025 earnings.

Q3 2025 Financial Highlights

  • During the subsequent period from October 1, 2025, to November 4, 2025, the
  • Company advanced approximately $3.3 million to existing borrowers on delayed draw term loan facilities.
  • As of September 30, 2025, the Company had approximately $101.7 million of total leverage, comprised of $52.4 million.
  • As of November 4, 2025, the Company has $69.1 million available on its secured revolving credit facility, and total liquidity, net of estimated liabilities, of approximately $63 million.

[Read More] 3 U.S. Cannabis Leaders to Watch in November 2025

NewLake Capital Partners, Inc.

NewLake Capital Partners, Inc. is an internally-managed real estate investment trust (REIT) that provides real estate capital to state-licensed cannabis operators through sale-leaseback transactions and third-party purchases and funding for build-to-suit projects. NLCP LOGO

In recent news, the company will have a speaker at the MJBizCon in Las Vegas. Anthony Coniglio, President and Chief Executive Officer, will attend MJBizCon 2025.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Research Suggests People Favor Medical Marijuana Over Prescription Medications

Research published in the International Journal of Drug Policy has discovered that…